Age weakens the immune system in quiet but dangerous ways. Vaccines stop working as well. Cancers escape detection more easily. Now a new study reports a surprising fix. Scientists turned the liver into a temporary immune support factory and reversed key signs of immune aging in mice.
Fast Facts
Discovery: Scientists temporarily used the liver to restore immune signals that fade with age. How: mRNA instructions prompted liver cells to produce key immune support factors for short periods. Result: Aged mice showed stronger vaccine responses and improved cancer immunity without autoimmune harm. Why It Matters: The findings suggest a safer way to boost aging immunity before vaccines or cancer treatment.
The research found that aging immune systems fail partly because critical support signals fade over time. These signals help young bodies produce fresh immune cells. When they decline, the immune system relies on worn out cells that respond slowly and poorly. The study shows that briefly restoring these signals can revive immune strength.
Researchers discovered that three immune support factors steadily drop with age. These include IL-7, FLT3L, and a Notch activating signal called DLL1. Together, they help create new T cells, which are white blood cells that recognize infections and cancer. Past efforts tried replacing these signals with injected proteins, but those caused inflammation or dangerous side effects.
Instead, the team used mRNA technology similar to COVID vaccines. They packaged mRNA instructions inside tiny lipid particles and delivered them to the liver. The liver then produced the missing immune signals for about two days. This short window mattered. It refreshed immune development without overstimulating the system.
To prove the effect, scientists tested aged mice that had weak immune responses. After treatment, the mice produced more naive T cells. These are young immune cells that can recognize new threats. Vaccine tests showed nearly double the number of virus specific T cells compared to untreated aged mice. Cancer experiments showed stronger tumor control and better response to immunotherapy.
This matters because immune aging affects nearly every disease. Older adults respond poorly to flu shots, COVID boosters, and cancer treatments. The study suggests that temporarily restoring immune signals could make existing therapies work better, without creating chronic inflammation.
Feng Zhang, one of the senior researchers, explained that the liver was chosen for a reason. It remains highly active even in old age and safely releases proteins into the bloodstream. By using mRNA, the effect stays reversible. Once dosing stops, the immune system returns to baseline, reducing long term risk .
The findings also connect to larger health challenges. As populations age worldwide, health systems face rising costs from infections, cancer, and weak vaccine protection. A short term immune boost before vaccination or cancer therapy could reduce hospitalizations and improve outcomes without lifelong treatment.
Next, researchers plan to test safety over longer periods and explore human trials. They stress that this is not immune enhancement for healthy people. It targets age related immune decline and still respects immune self control. The study used multiple autoimmune disease models and found no increase in harmful immune attacks.
The takeaway is simple but powerful. Aging immunity may not be broken. It may just be missing signals that the body once had. By briefly restoring those signals, scientists showed it is possible to give the immune system a second wind.
Story Source:
Materials provided by Insert Institution Here. Content may be edited for style and length.
Journal Reference:
Mirco J. Friedrich, Julie Pham, Jiakun Tian, Hongyu Chen, Jiahao Huang, Niklas Kehl, Sophia Liu, Blake Lash, Fei Chen, Xiao Wang, Rhiannon K. Macrae, Feng Zhang. Transient hepatic reconstitution of trophic factors enhances aged immunity. Nature, 2025. Volume(Issue). DOI: 10.1038/s41586-025-09873-4